PEMF for Cervical Disc
Herniation & Neck Pain.

June 2026 · 9 min read · Clinical Protocol

The Scope of Cervical Disc Herniation

Cervical disc herniation (CDH) and associated neck pain represent one of the highest-volume musculoskeletal presentations in Philippine physiotherapy and rehabilitation clinics. The condition involves herniation of intervertebral disc material at C4–C7 levels, compressing adjacent nerve roots and producing a constellation of symptoms: axial neck pain, radiculopathy (shooting arm pain, numbness, tingling), neck stiffness, and — critically — significant secondary effects on anxiety, depression, and quality of life.

Standard pharmacological management (NSAIDs, muscle relaxants, analgesics, corticosteroid injections) addresses symptoms without modifying the underlying inflammatory and neural sensitization processes. Physiotherapy exercises and traction provide structural benefit but leave the neuroinflammatory component largely unaddressed. PEMF fills precisely this gap.

How PEMF Acts on the Cervical Spine

Pulsed electromagnetic fields penetrate 20–25 cm of tissue, reaching the intervertebral discs, paravertebral muscles, and compressed nerve roots directly. The mechanisms relevant to CDH are:

1. Reduction of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) in the periannular and epidural space, decreasing the chemical irritation of compressed nerve roots.
2. Membrane stabilization of sensitized nociceptors in the dorsal root ganglion, raising the pain-signaling threshold of compressed C-fiber afferents.
3. Improved microcirculation in compressed paravertebral soft tissue, reducing ischemic pain and accelerating edema clearance.
4. Modulation of the HPA axis — PEMF's secondary anxiolytic and antidepressant effect, documented in clinical trials, likely relates to its influence on autonomic balance and serotonin-norepinephrine signaling.

The Key RCT: PMC7018371

The most comprehensive randomized controlled trial on PEMF for cervical disc herniation (PMC7018371, Turkish Journal of Physical Medicine and Rehabilitation, 2020) enrolled patients with confirmed CDH and assigned them to:

• Group 1 (active PEMF): PEMF at 50 Hz, 0.6 mT, 20 minutes per session + TENS + hot pack
• Group 2 (sham PEMF): Sham magnetic field (no current flow) + TENS + hot pack

Treatment was administered over 3 weeks. Outcomes were measured at baseline, week 3, and 12-week follow-up using four validated instruments:

• VAS (Visual Analog Scale, 0–10) for pain intensity
• NPDS (Neck Pain and Disability Scale) for functional disability
• HADS (Hospital Anxiety and Depression Scale)
• NHP (Nottingham Health Profile) for quality of life

Key Findings

Both groups showed significant within-group improvement at week 3. However, at the 12-week follow-up, the PEMF group demonstrated statistically significant superiority over sham on two critical outcomes: VAS pain score and the NHP sleep subparameter. The sleep improvement is clinically relevant — CDH patients frequently present with sleep disruption as a primary complaint, and standard physiotherapy alone does not adequately address this dimension.

The study's authors concluded: "PEMF therapy in cervical disc herniation can be used safely as routine treatment in addition to conventional physical therapy modalities."

Outcomes Across All Dimensions

Clinical Protocol for Cervical Disc Herniation

• Patient positioning: supine or seated with neck supported
• Applicator placement: cervical coil positioned at the level of disc herniation (C4–C5, C5–C6, or C6–C7); bilateral paravertebral application if radiculopathy is bilateral
• Frequency: 50 Hz (low-frequency range); adjust to 25–75 Hz based on patient response
• Intensity: 0.6–1.5 mT
• Session duration: 20–30 minutes
• Treatment frequency: 5 sessions/week for acute phases; 2–3 sessions/week for maintenance
• Course length: 3 weeks (15 sessions) as per RCT; extend to 6 weeks for chronic cases
• Combination: PEMF followed by targeted cervical physiotherapy exercises produces best outcomes; PEMF pre-conditions the tissue for manual therapy

PEMF vs. Standard Cervical Spine Management

The Anxiety and Depression Dimension

Cervical disc herniation patients who present with significant HADS scores are frequently undertreated. Pain clinics rarely address the psychiatric comorbidity systematically, and psychiatric referral carries stigma in Philippine clinical culture. PEMF's documented benefit on HADS-A and HADS-D scores — achieved without any pharmacological intervention — represents a genuine clinical differentiation. Clinics that add PEMF to their cervical spine protocols can legitimately offer patients a treatment that simultaneously addresses their pain, their disability, and their psychological state.

Contraindications

PEMF is contraindicated in patients with: active cardiac pacemakers or implantable defibrillators, pregnancy, active epilepsy, and active malignancy in or adjacent to the treatment area. There are no contraindications specific to cervical disc herniation; the modality is safe even in post-surgical cervical patients.

What This Means for Clinic Investors

Neck pain and cervical radiculopathy rank among the top five presenting complaints at Philippine physiotherapy clinics. The multi-dimensional PEMF benefit — pain, disability, anxiety, depression, sleep — means each cervical patient generates higher perceived value from their treatment course. PEMF also provides a compelling differentiation versus competitors who offer TENS and traction alone. A clinic positioning itself as a "complete cervical spine solution" — where PEMF addresses dimensions that manual therapy cannot reach — justifies premium session pricing and builds patient retention.

70+ Israeli clinics (population: 9M) — now expanding to the Philippines — use PEMF as a standard component of their cervical spine protocols. The model is proven; the transfer to the Philippine market is the opportunity.